1. Introduction {#sec1}
===============

Nonurothelial tumors of the urinary bladder represent less than 5% of all bladder tumors, with sarcoma being the most common of which \[[@B1]\]. Angiosarcoma, one of the rarest types of sarcoma, arises from the endothelial layer of blood vessels. It is a highly aggressive cancer and carries very poor prognosis. Only 12 cases of primary angiosarcoma of the urinary bladder have been reported so far \[[@B2]\].

2. Case Presentation {#sec2}
====================

2.1. The Patient {#sec2.1}
----------------

An 89-year-old male presented to ER with massive hematuria. Two large caliber intravenous cannulas were placed and blood tests for CBC, biochemistry, and blood type were taken. A 3-way 22Fr catheter was urethrally inserted and bladder irrigation with normal saline started. His past medical history included T1 prostatic adenocarcinoma for which he received external beam radiotherapy 12 years ago. His physical examination and digital rectal examination were unremarkable. His creatinine was 0.9 mg/dL, PSA was 0.26 ng/mL, and cytology was negative for malignant cells. CT-Urography demonstrated a large highly vascular mass with irregular margins originating from the left bladder wall ([Figure 1(a)](#fig1){ref-type="fig"}). Computed tomography also showed severe left-sided hydronephrosis and hydroureter ([Figure 1(b)](#fig1){ref-type="fig"}) and lytic lesions in the vertebrae and pelvic bones suspected as metastases. Cystoscopy showed a large solid mass arising from the bladder base which was resected transurethrally.

2.2. Histopathology {#sec2.2}
-------------------

Macroscopically, the specimen was 6 × 5 × 4 cm^3^ of grey tissue and blood clots. Microscopically, the tissue diagnosis was consistent with primary angiosarcoma of urinary bladder invading muscularis layer, with anastomosing vascular channels ([Figure 2(a)](#fig2){ref-type="fig"}). The tumor strongly stained for CD31 and CD34 and focally for fVIII (Figures [2(b)](#fig2){ref-type="fig"} and [2(c)](#fig2){ref-type="fig"}), three markers for endothelial cells, and was negative for Keratin P63, a marker of epithelial cells ([Figure 2(d)](#fig2){ref-type="fig"}). No prostatic tissue was found in the specimen.

2.3. Treatment {#sec2.3}
--------------

The patient was referred to palliative radiotherapy because of symptomatic spinal metastasis. The patient was consulted about the option of chemotherapy but he denied. The patient died 3 months after the initial diagnosis.

3. Discussion {#sec3}
=============

Nonurothelial neoplasms of the urinary bladder are extremely rare. Of these neoplasms, sarcoma represents the most common nonurothelial neoplasm of the urinary bladder \[[@B1]\]. The most common sarcoma of the bladder is leiomyosarcoma, which accounts for more than half of the sarcomas \[[@B1]\]. Angiosarcoma of the urinary bladder is a very rare subtype of sarcoma with only 12 reported cases \[[@B2]\]. All 12 cases reported presented with hematuria, 11 with gross hematuria, and one with microscopic hematuria. Almost all cases were muscle-invasive tumors. Twelve patients\' characteristics are summarized in [Table 1](#tab1){ref-type="table"}. Histological and immunohistochemical features are summarized in [Table 2](#tab2){ref-type="table"}.

Four cases of secondary angiosarcoma of the bladder were previously reported, originating from the penis \[[@B3]\], pelvis \[[@B4]\], Kaposi\'s sarcoma \[[@B5]\], and vagina \[[@B6]\].

Angiosarcoma is a very aggressive tumor carrying poor prognosis \[[@B7]\]. Most of the angiosarcomas are at least muscle-invasive when diagnosed \[[@B8]\]. Hematuria, the most common presenting symptom, may be life-threatening. Histolopathology mostly establishes the diagnosis, with typical microscopic features and immunohistochemical staining \[[@B8]\]. Cytology may be helpful in some cases \[[@B9]\].

Prior radiation is a well-documented risk factor \[[@B4]\] and should raise a suspicion of angiosarcoma in patients with hematuria and no evidence of urothelial carcinoma. Of the 13 angiosarcoma cases reported, including the one we are reporting, 38% were related to prior exposure to radiotherapy.

Because of the small number of patients reported, there is no accepted gold-standard treatment. Suggested treatment options include chemotherapy, radiotherapy, and radical surgery, with some sort of combinations \[[@B2], [@B8]\].
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![Computed tomography of our patient. (a) Highly vascular mass originating from the left bladder wall, but a prostatic origin could not be absolutely rolled out by CT. (b) Hydronephrosis on the left side and coronal view of the mass.](CRIONM2015-652870.001){#fig1}

![Histopathology and immunohistochemistry. (a) Typical appearance of anastomosing vascular channels as seen with H&E. (b) Tumor cells stain positive for CD34. (c) Tumor cells stain positive for CD31. (d) Tumor cells do not stain for cytokeratin.](CRIONM2015-652870.002){#fig2}

###### 

All reported patients\' characteristics.

  Patient   Age/sex   Etiology                  Presentation                                 Author/year
  --------- --------- ------------------------- -------------------------------------------- -----------------------------------
  1         54/M      Hemangioma                Hematuria and obstruction                    Jungano, 1907 \[[@B10]\]
  2         85/F      Hemangioma                Hematuria, dysuria, and weight loss          Casal et al., 1970 \[[@B11]\]
  3         68/M      Primary                   Hematuria                                    Stroup and Chang 1987 \[[@B12]\]
  4         78/M      Primary                   Hematuria, dysuria                           Aragona et al., 1991 \[[@B13]\]
  5         55/M      Primary                   Hematuria                                    Ravi, 1993 \[[@B14]\]
  6         78/M      RT 13 years prior to Dx   Hematuria                                    Navon et al., 1997 \[[@B15]\]
  7         47/M      Primary                   Hematuria, flank pain, and suprapubic pain   Engel et al., 1998 \[[@B7]\]
  8         47/M      Primary                   Dysuria and subsequent hematuria             Schindler et al., 1999 \[[@B16]\]
  9         66/M      RT 4 years prior to Dx    Hematuria                                    Seethala et al., 2006 \[[@B8]\]
  10        83/F      RT 14 years prior to Dx   Microhematuria                               Kulaga et al., 2007 \[[@B17]\]
  11        71/M      RT 10 years prior to Dx   Hematuria                                    Williams et al., 2008 \[[@B18]\]
  12        32/F      Primary                   Flank pain, hematuria                        Warne et al., 2011 \[[@B2]\]
  Current   89/M      RT 13 years prior to Dx   Hematuria                                    Bahouth, 2015

###### 

Histopathology and immunohistochemistry of all patients reported.

  Patient   Stage                     Histology                                             Immunophenotype                                    Author/year
  --------- ------------------------- ----------------------------------------------------- -------------------------------------------------- -----------------------------------
  1         N/A                       Classic, focally with large dilated vascular spaces   N/A                                                Jungano, 1907 \[[@B10]\]
  2         N/A                       Classic, focally solid                                N/A                                                Casal et al., 1970 \[[@B11]\]
  3         At least lamina propria   Typical, "hobnail" cells                              fVIII+, keratin−                                   Stroup and Chang 1987 \[[@B12]\]
  4         T3                        Typical                                               fVIII+, keratin−                                   Aragona et al., 1991 \[[@B13]\]
  5         T2                        Typical                                               N/A                                                Ravi, 1993 \[[@B14]\]
  6         T3                        Typical                                               fVIII+, CD34+                                      Navon et al., 1997 \[[@B15]\]
  7         T4N0M0                    Solid and primitive                                   fVIII+, CD31+, CD34+                               Engel et al., 1998 \[[@B7]\]
  8         TXN + M0                  Solid, focally classic                                fVIII−, CD34−, keratin−, CD31+                     Schindler et al., 1999 \[[@B16]\]
  9         Peritoneal surface        Solid, focally primitive                              CD31+, CD43+, kertin−                              Seethala et al., 2006 \[[@B8]\]
  10        Muscularis                Typical                                               CD31+, CD34−, fVIII−                               Kulaga et al., 2007 \[[@B17]\]
  11        T4                        Typical                                               fVIII+, CD31+, CD34+                               Williams et al., 2008 \[[@B18]\]
  12        MIBC                      Typical                                               fVIII+, CD31+, CD34+                               Warne et al., 2011 \[[@B2]\]
  Current   MIBC                      Typical                                               CD31+, CD34+, fVIII+, keratin−; cystitis cystica   Bahouth, 2015

Typical appearance includes anastomosing vascular channels. N/A: not available. MIBC = muscle-invasive bladder cancer.
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